Georgiamune
Innate immune modulation platform that activates anti-tumor and anti-pathogen immune responses
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 39 pending · first 2024
- Rank in peer group#73 of 342
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 342 peers
Line = medianBiotech · Platform
- Granted patents#73 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 40- PendingAKT3 ModulatorsUSPTOApplication 18707109
- PendingAKT3 ModulatorsUSPTOApplication 18707103
- PendingAntibodies To Programmed Cell Death Protein 1 That Are PD-1 AgonistsUSPTOApplication 18943339
Show all 40 patent records
- AKT3 ModulatorsJun 11, 2026 · Application 18707109Pending
- AKT3 ModulatorsJun 11, 2026 · Application 18707103Pending
- Antibodies To Programmed Cell Death Protein 1 That Are PD-1 AgonistsMay 1, 2025 · Application 18943339Pending
- AKT3 ModulatorsMar 6, 2025 · Application 18707078Pending
- Polypeptide ModulatorsFeb 13, 2025 · Application 18718397Pending
- AKT3 ModulatorsJan 2, 2025 · Application 18707125Pending
- Antibodies To Programmed Cell Death Protein 1 That Are PD-1 AgonistsDec 17, 2024 · US 12,168,687Granted
- AKT3 ModulatorsJul 11, 2024 · Application 17923811Pending
- AKT3 ModulatorsSep 21, 2023 · Application 17923837Pending
- AKT3 ModulatorsJul 13, 2023 · Application 17923779Pending
- AKT3 Modulators And Methods Of Use ThereofJun 15, 2023 · Application 17923696Pending
- AKT3 ModulatorsJun 15, 2023 · Application 17923707Pending
- AKT3 ModulatorsApplication 63276338Pending
- Itk ModulatorsApplication PCTUS2026017265Pending
- Novel PD-L2 MutantsApplication 19490686Pending
- Itk ModulatorsApplication 63765948Pending
- AKT3 ModulatorsApplication 63276073Pending
- AKT3 ModulatorsApplication 63276115Pending
- AKT3 ModulatorsApplication 63276218Pending
- AKT3 ModulatorsApplication PCTUS2021031325Pending
- AKT3 Modulators And Methods Of Use ThereofApplication PCTUS2021031372Pending
- AKT3 ModulatorsApplication PCTUS2021031297Pending
- AKT3 ModulatorsApplication PCTUS2021031386Pending
- AKT3 ModulatorsApplication PCTUS2021031381Pending
- ModulatorsApplication 63121000Pending
- ModulatorsApplication 63121077Pending
- ModulatorsApplication 63120984Pending
- ModulatorsApplication 63121001Pending
- Modulators And Methods Of Use ThereofApplication 63021797Pending
- ModulatorsApplication 63022111Pending
- ModulatorsApplication 63021987Pending
- ModulatorsApplication 63021727Pending
- Antibodies To Cytotoxic T-lymphocyte Associated Protein 4 That Potentiate T Cell ActivationApplication PCTUS2025060048Pending
- ModulatorsApplication 63021981Pending
- Antibodies To Cytotoxic T-lympthocyte Associated Protein 4 That Potentiate T Cell ActivationApplication 63735532Pending
- Novel PD-L2 MutantsApplication PCTUS2024032759Pending
- PD-L2 MutantsApplication 63471298Pending
- Antibodies To Programmed Cell Death Protein 1 That Are PD-1 AgonistsApplication PCTUS2023061449Pending
- Polypeptide ModulatorsApplication PCTUS2022081186Pending
- AKT3 ModulatorsApplication PCTUS2022079334Pending
Related companies, and why
- Seek Laboratories, Inc.Similar federal contract value in Biotech · null in contracts
- Kanvas Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Cantai Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Rinascera Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Greenwich LifeSciences, Inc.Similar federal contract value in Biotech · null in contracts
- Cellective BioTherapy, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .